Literature DB >> 12734275

Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis.

Claudine Pinel1, Hélène Fricker-Hidalgo, Bernadette Lebeau, Frédéric Garban, Rébecca Hamidfar, Pierre Ambroise-Thomas, Renée Grillot.   

Abstract

The effectiveness of galactomannan detection with the Platelia test was evaluated in a prospective study of 3,327 sera from 807 patients. The specificity was 99.6% (748 of 751 cases). For the groups of patients with proven and probable invasive aspergillosis, the sensitivity was 50.0% (17 of 34 cases). The disappointing sensitivity associated with the presence of rare false-positive cases underlines the limits of this test.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12734275      PMCID： PMC154675          DOI： 10.1128/JCM.41.5.2184-2186.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Transient aspergillus antigenaemia: think of milk.

Authors:  Jean-Pierre Gangneux; Dominique Lavarde; Stéphane Bretagne; Claude Guiguen; Virginie Gandemer
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

2.  Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis.

Authors:  R Kappe; A Schulze-Berge; H G Sonntag
Journal:  Mycoses       Date:  1996 Jan-Feb       Impact factor: 4.377

3.  The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergilosis (IPA).

Authors:  M Siemann; M Koch-Dörfler
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

4.  Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.

Authors:  L Hovi; U M Saarinen-Pihkala; K Vettenranta; H Saxen
Journal:  Bone Marrow Transplant       Date:  2000-11       Impact factor: 5.483

5.  Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease.

Authors:  François Boutboul; Corinne Alberti; Thierry Leblanc; Annie Sulahian; Eliane Gluckman; Francis Derouin; Patricia Ribaud
Journal:  Clin Infect Dis       Date:  2002-02-20       Impact factor: 9.079

6.  Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

Authors:  Raoul Herbrecht; Valérie Letscher-Bru; Corina Oprea; Bruno Lioure; Jocelyn Waller; France Campos; Odile Villard; Kun-Lun Liu; Shanti Natarajan-Amé; Patrick Lutz; Patrick Dufour; Jean-Pierre Bergerat; Ermanno Candolfi
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

Review 7.  New perspectives in the diagnosis of systemic fungal infections.

Authors:  M D Richardson; M H Kokki
Journal:  Ann Med       Date:  1999-10       Impact factor: 4.709

8.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

9.  Computed tomographic scan of the chest, latex agglutination test and plasma (1AE3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients.

Authors:  M Kami; Y Tanaka; Y Kanda; S Ogawa; T Masumoto; K Ohtomo; T Matsumura; T Saito; U Machida; T Kashima; H Hirai
Journal:  Haematologica       Date:  2000-07       Impact factor: 9.941

10.  Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.

Authors:  J Maertens; J Verhaegen; H Demuynck; P Brock; G Verhoef; P Vandenberghe; J Van Eldere; L Verbist; M Boogaerts
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948
View more
  26 in total

1.  Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period.

Authors:  Daniel C Zedek; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Rodrigo Martino; Rocio Parody; Takahiro Fukuda; Johan Maertens; Koen Theunissen; Aloysius Ho; Ghulam J Mufti; Nicolaus Kroger; Arnold R Zander; Dominik Heim; Monika Paluszewska; Dominik Selleslag; Katerina Steinerova; Per Ljungman; Simone Cesaro; Anna Nihtinen; Catherine Cordonnier; Lourdes Vazquez; Monica López-Duarte; Javier Lopez; Rafael Cabrera; Montserrat Rovira; Stefan Neuburger; Oliver Cornely; Ann E Hunter; Kieren A Marr; Hans Jürgen Dornbusch; Hermann Einsele
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

3.  Quick and reliable galactomannan detection in crude minced lung specimens from haematological patients with suspected invasive fungal infection: results from a case series.

Authors:  D D'Antonio; A Manna; V Savini; D Onofrillo; G Di Bonaventura; R Piccolomini; G Parruti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-04       Impact factor: 3.267

4.  Gluconate-containing intravenous solutions: another cause of false-positive galactomannan assay reactivity.

Authors:  Ignace Surmont; Willem Stockman
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

Review 5.  Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

Authors:  Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack Sobel; Claudio Viscoli; Thomas J Walsh; Johan Maertens; Thomas F Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John R Graybill; Lindsey R Baden; Peter G Pappas; John E Bennett; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart-Jan Kullberg; William E Dismukes; Ben E De Pauw
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

6.  Reproducibility of low galactomannan enzyme immunoassay index values tested in multiple laboratories.

Authors:  Arlo Upton; Anja Gugel; Wendy Leisenring; Ajit Limaye; Barbara Alexander; Randall Hayden; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients.

Authors:  Shun-Ichi Kimura; Jun Odawara; Takatoshi Aoki; Masayuki Yamakura; Masami Takeuchi; Kosei Matsue
Journal:  Int J Hematol       Date:  2009-10-20       Impact factor: 2.490

8.  Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure.

Authors:  Monique A S H Mennink-Kersten; Dorien Ruegebrink; Rocus R Klont; Adilia Warris; Nicole M A Blijlevens; J Peter Donnelly; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2008-02-20       Impact factor: 5.948

9.  Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction.

Authors:  Thomas J Walsh; Shmuel Shoham; Ruta Petraitiene; Tin Sein; Robert Schaufele; Amy Kelaher; Heidi Murray; Christine Mya-San; John Bacher; Vidmantas Petraitis
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 10.  Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature.

Authors:  Isabella Eckerle; Damaris Ebinger; Daniel Gotthardt; Ralf Eberhardt; Philipp A Schnabel; Wolfgang Stremmel; Thomas Junghanss; Christoph Eisenbach
Journal:  Malar J       Date:  2009-07-20       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.